Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.44
MRIC's Cash to Debt is ranked lower than
79% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. MRIC: 0.44 )
Ranked among companies with meaningful Cash to Debt only.
MRIC' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.74 Max: N/A
Current: 0.44
Equity to Asset -0.44
MRIC's Equity to Asset is ranked lower than
95% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. MRIC: -0.44 )
Ranked among companies with meaningful Equity to Asset only.
MRIC' s Equity to Asset Range Over the Past 10 Years
Min: -7.21  Med: -0.59 Max: -0.01
Current: -0.44
-7.21
-0.01
F-Score: 4
Z-Score: -14.15
M-Score: -2.28
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -159.98
MRIC's Operating margin (%) is ranked lower than
82% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 2.36 vs. MRIC: -159.98 )
Ranked among companies with meaningful Operating margin (%) only.
MRIC' s Operating margin (%) Range Over the Past 10 Years
Min: -356.5  Med: -172.64 Max: -61.86
Current: -159.98
-356.5
-61.86
Net-margin (%) -131.52
MRIC's Net-margin (%) is ranked lower than
80% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.77 vs. MRIC: -131.52 )
Ranked among companies with meaningful Net-margin (%) only.
MRIC' s Net-margin (%) Range Over the Past 10 Years
Min: -354.22  Med: -182.09 Max: -112.83
Current: -131.52
-354.22
-112.83
ROA (%) -75.65
MRIC's ROA (%) is ranked lower than
89% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: -0.34 vs. MRIC: -75.65 )
Ranked among companies with meaningful ROA (%) only.
MRIC' s ROA (%) Range Over the Past 10 Years
Min: -548.58  Med: -105.56 Max: -42.57
Current: -75.65
-548.58
-42.57
ROC (Joel Greenblatt) (%) -1173.15
MRIC's ROC (Joel Greenblatt) (%) is ranked lower than
87% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. MRIC: -1173.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MRIC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1555.63  Med: -601.46 Max: -248.36
Current: -1173.15
-1555.63
-248.36
Revenue Growth (3Y)(%) -21.30
MRIC's Revenue Growth (3Y)(%) is ranked lower than
86% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. MRIC: -21.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MRIC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.1  Med: -36.60 Max: -21.3
Current: -21.3
-44.1
-21.3
EBITDA Growth (3Y)(%) 11.50
MRIC's EBITDA Growth (3Y)(%) is ranked higher than
64% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. MRIC: 11.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MRIC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -54.2  Med: -46.30 Max: 11.5
Current: 11.5
-54.2
11.5
EPS Growth (3Y)(%) -7.40
MRIC's EPS Growth (3Y)(%) is ranked lower than
62% of the 202 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. MRIC: -7.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MRIC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -55.4  Med: -47.40 Max: -7.4
Current: -7.4
-55.4
-7.4
» MRIC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with MRIC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:ASX:MX1, ASX:UBI, NAS:MSON, BOM:532391, AMEX:ELMD, OTCPK:BSGM » details
MRI Interventions Inc is a medical device company. It develops & commercializes technology enabling physicians to see inside the brain & heart using direct, intra-procedural MRI guidance while performing minimally invasive surgical procedures.

MRI Interventions Inc is a medical device company incorporated in the state of Delaware in March 1998. The Company is engaged in the development and commercialization of technology that enables physicians to see inside the brain and heart using direct, intra-procedural magnetic resonance imaging ("MRI") guidance while performing minimally invasive surgical procedures. The Company's ClearPoint system, an integrated system comprised of reusable and disposable products, is designed to allow minimally invasive procedures in the brain to be performed in an MRI suite. The Company's ClearTrace system is a product candidate under development that is designed to allow catheter-based minimally invasive procedures in the heart to be performed in an MRI suite. The Company faces competitions from companies including Medtronic plc, St. Jude Medical Inc. and Biosense Webster Inc., a division of Johnson & Johnson. The Company is subject to extensive regulation by the FDA and various other federal, state and foreign governmental authorities.

Ratios

vs
industry
vs
history
P/S 5.08
MRIC's P/S is ranked lower than
71% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. MRIC: 5.08 )
Ranked among companies with meaningful P/S only.
MRIC' s P/S Range Over the Past 10 Years
Min: 4.29  Med: 13.67 Max: 22.17
Current: 5.08
4.29
22.17
Current Ratio 2.09
MRIC's Current Ratio is ranked lower than
64% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. MRIC: 2.09 )
Ranked among companies with meaningful Current Ratio only.
MRIC' s Current Ratio Range Over the Past 10 Years
Min: 0.11  Med: 1.11 Max: 2.38
Current: 2.09
0.11
2.38
Quick Ratio 1.61
MRIC's Quick Ratio is ranked lower than
63% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. MRIC: 1.61 )
Ranked among companies with meaningful Quick Ratio only.
MRIC' s Quick Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.88 Max: 1.98
Current: 1.61
0.04
1.98
Days Inventory 298.51
MRIC's Days Inventory is ranked lower than
82% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. MRIC: 298.51 )
Ranked among companies with meaningful Days Inventory only.
MRIC' s Days Inventory Range Over the Past 10 Years
Min: 269.58  Med: 325.98 Max: 613.48
Current: 298.51
269.58
613.48
Days Sales Outstanding 109.84
MRIC's Days Sales Outstanding is ranked lower than
76% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 69.05 vs. MRIC: 109.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
MRIC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.11  Med: 47.50 Max: 96.77
Current: 109.84
32.11
96.77
Days Payable 129.87
MRIC's Days Payable is ranked higher than
78% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. MRIC: 129.87 )
Ranked among companies with meaningful Days Payable only.
MRIC' s Days Payable Range Over the Past 10 Years
Min: 128.15  Med: 353.70 Max: 2246.2
Current: 129.87
128.15
2246.2

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.37
MRIC's Price/Median PS Value is ranked higher than
89% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. MRIC: 0.37 )
Ranked among companies with meaningful Price/Median PS Value only.
MRIC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.37  Med: 0.98 Max: 1.56
Current: 0.37
0.37
1.56
Earnings Yield (Greenblatt) (%) -14.93
MRIC's Earnings Yield (Greenblatt) (%) is ranked lower than
77% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. MRIC: -14.93 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MRIC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -30.52  Med: 0.00 Max: 0
Current: -14.93
-30.52
0

More Statistics

Revenue (TTM) (Mil) $4.98
EPS (TTM) $ -0.08
Beta0.29
Short Percentage of Float0.00%
52-Week Range $0.25 - 1.18
Shares Outstanding (Mil)95.89

Analyst Estimate

Dec16
Revenue (Mil $)
EPS ($) -0.08
EPS without NRI ($) -0.08
EPS Growth Rate
(3Y to 5Y Estimate)
20.00%
» More Articles for MRIC

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
MRI INTERVENTIONS, INC. Financials May 17 2016
MRI INTERVENTIONS, INC. Files SEC form 10-Q, Quarterly Report May 06 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2016
MRI Interventions, Inc. Announces 2016 First Quarter Results Apr 28 2016
MRI Interventions, Inc. Announces 2016 First Quarter Results Apr 28 2016
The ClearPoint® Neuro Navigation System Featured at AANS Practical Clinics for Third Consecutive... Apr 26 2016
MRI Interventions, Inc. Announces Fiscal 2016 First Quarter Financial Results Conference Call and... Apr 25 2016
Zero DBS Electrode Infections Reported When Utilizing the ClearPoint® NeuroNavigation System in an... Apr 20 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Apr 04 2016
MRI Interventions, Inc. :MRIC-US: Earnings Analysis: 2015 By the Numbers Mar 28 2016
MRI INTERVENTIONS, INC. Files SEC form 10-K, Annual Report Mar 25 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Mar 24 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 23 2016
MRI Interventions, Inc. Announces 2015 Fourth Quarter and Full Year Results Mar 23 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of... Mar 22 2016
MRI Interventions, Inc. Announces Agreement to Restructure Brainlab AG Senior Secured Note Mar 22 2016
MRI Interventions, Inc. Announces Fiscal 2015 Fourth Quarter and Full Year Financial Results... Mar 22 2016
Equities Lead Investor Sentiment - Complementary Research on Friendable, Bombardier, Silvercorp... Jan 15 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 07 2016
MRI INTERVENTIONS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities Dec 21 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)